1. Higher Risk Patients Under Hypomethylating Agents – A Multicentric Experience from Latin America. (April 2017) Authors: Belli, C.; Lazzarino, C.; Arbelbide, J.; Basquiera, A.L.; Rivas, M.M.; Pintos, N.; Fernandez, V.; Posse Cobarco, J.; Prates, M.V.; Gonzalez, J.; Crisp, R.; Alfonso, G.; Espinosa, D.; Viñuales, E.; Narbaitz, M.; Cabrejo, M.; Campestri, R.; Grillé, S.; Iastrebner, M. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S59 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Lower-Risk Patients that Required Hypomethylating Agents. A Multicentric Experience from Latin America. (April 2017) Authors: Iastrebner, M.; Belli, C.; Lazzarino, C.; Fantl, D.; Pintos, N.; Bengio, R.; Prates, M.V.; Rosenhain, M.; Pose, J.; Celebrin, L.; Moro, D.; Garcia Rivello, H.; Grille, S.; Flores, G.; Rivas, M.M.; Enrico, A.; Abello Polo, V.; Araujo Schuster, S.; Arbelbide, J.; Consortium, I. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S64 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P764: RESPONSE AND SURVIVAL OUTCOMES WITH HYPOMETHYLATING AGENTS IN AN ARGENTINEAN COHORT OF 113 PATIENTS WITH CHRONIC MYELOMONOCITIC LEUKEMIA. (23rd June 2022) Authors: Gonzalez, J.; Perusini, A.; Russo, F.; Fuentes, L.; Deluca, T.; Basquiera, A. L.; Navickas, A.; Kornblihtt, L.; Pintos, N.; Nucifora, E.; Iastrebner, M.; Enrico, A.; Arbelbide, J.; Belli, C. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 659 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗